// App-Quantinova.ai

POS1330 (2021) : SAFETY OF ANAKINRA IN PATIENTS WITH CRYOPYRIN ASSOCIATED PERIODIC SYNDROMES (CAPS) USING A GRADUATED PRE-FILLED SYRINGE

Researchers

Presenter

  • R. Papa

Principal Investigators

  • G. Giancane

  • H. J. Lachmann

  • P. Brogan

  • D. Lindqvist

  • S. Cederholm

  • F. Bagnasco

  • N. Ruperto

  • M. Gattorno

Medical Centers

  • IRCCS Istituto Giannina Gaslini, UOSD Centro Malattie Autoinfiammatorie ed Immunodeficienze, Genoa, Italy

  • Università degli Studi di Genova, Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili (DiNOGMI), Genoa, Italy, Genova, Italy

  • IRCCS Istituto Giannina Gaslini, Clinica Pediatrica e Reumatologia, PRINTO, Genoa, Italy

  • Royal Free London, National Amyloidosis Centre, London, United Kingdom

  • UCL Institute of Child Health, Great Ormond Street Hospital, Infection, Inflammation and Rheumatology Unit, London, United Kingdom

  • Beatrix Kinderkliniek, University Medical Center, Department of Pediatric Rheumatology, Groningen, Netherlands

  • Sobi, Stockholm, Sweden

  • IRCCS Istituto Giannina Gaslini, Epidemiologia e Biostatistica, Genova, Italy

  • IRCCS Istituto Giannina Gaslini, Clinica Pediatrica e Reumatologia, PRINTO, Genoa, Italy

Locations

  • Italy

  • United Kingdom

  • Netherlands

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Cryopyrin associated periodic syndrome

Biomarkers

  • Interleukin 1

Drug/Treatment

  • Anakinra

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved